Page 48 - ரோச் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Roche says adding Actemra to Gilead s remdesivir didn t cut COVID patient hospital stays
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Prejšnji teden potrdili 155 primerov angleške različice novega koronavirusa #video
siol.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from siol.net Daily Mail and Mail on Sunday newspapers.
Roche withdraws US indication for Tecentriq in bladder cancer
10th March 2021
Swiss pharma company Roche has announced that it will withdraw the US indication for Tecentriq in prior-platinum treated metastatic urothelial carcinoma (mUC, bladder cancer).
The US Food and Drug Administration (FDA) granted Tecentriq (atezolizumab) accelerated approval for this indication based on the results from the IMvigor210 study.
For continued approval in bladder cancer, Tecentriq had to yield positive results in this trial as part of the specific post-marketing requirements (PMR) set out by the FDA to confirm the clinical benefit of the immunotherapy.
However, the study did not meet its primary endpoint of overall survival in the PD-L1 high patient population.
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare - a strategy that aims to fit the right treatment to each patient in the best way possible.
Roche is the world s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
Kevin Roche John Dinkeloo and Associates Relaunches as Roche Modern
The firm continues to offer its celebrated cross-disciplinary design services in pursuit of a modernist future.
NEW HAVEN, Conn., March 9, 2021 /PRNewswire/ Kevin Roche John Dinkeloo and Associates (aka Roche Dinkeloo ) has announced a relaunch as Roche Modern. The firm will continue to offer its celebrated cross-disciplinary design services blending architecture, engineering, sculpture and energy systems in pursuit of a modernist future. It s an honor to carry on my father s legacy by joining the seasoned architects who worked alongside Kevin with the next generation of talented young designers and technologies. said Eamon Roche, son of Kevin Roche.
vimarsana © 2020. All Rights Reserved.